Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00792142 Information provided by City of Hope Medical Center

First Received: November 14, 2008 Last Updated: October 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)